The Journal of Allergy and Clinical Immunology
Volume 120, Issue 1 , Pages 25-31 , July 2007

Traditional Chinese herbal remedies for asthma and food allergy

  • Xiu-Min Li, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Xiu-Min Li, MD, Department of Pediatrics, Mount Sinai School of Medicine, One Gustave L. Levy Place, Pediatrics Box 1198, New York, NY 10029.

Received 16 March 2007 ,Revised 25 April 2007 ,Accepted 26 April 2007.

References 

  1. Ko J, Lee JI, Munoz-Furlong A, Li XM, Sicherer SH. Use of complementary and alternative medicine by food-allergic patients. Ann Allergy Asthma Immunol. 2006;97:365–369
  2. Hassed C. An integrative approach to asthma. Aust Fam Physician. 2005;34:573–576
  3. Bielory L, Russin J, Zuckerman GB. Clinical efficacy, mechanisms of action, and adverse effects of complementary and alternative medicine therapies for asthma. Allergy Asthma Proc. 2004;25:283–291
  4. Bensky D, Clavey S, Stoger E, Gamble . Chinese herbal medicine: materia medica. 3rd ed.. Seattle: Eastland Press; 2004;
  5. Snyderman R. Integrative medicine: a foundation for prospective health care. Distinguished Lecture in the Science of Complementary and Alternative Medicine. National Center for Complementary and Alternative Medicine. 2005;Available at: http://nccam.nih.gov/news/newsletter/2005_summer/integrative.htm. Accessed March 2007
  6. Cohen MH, Sandler L, Hrbek A, Davis RB, Eisenberg DM. Policies pertaining to complementary and alternative medical therapies in a random sample of 39 academic health centers. Altern Ther Health Med. 2005;11:36–40
  7. Wen MC, Wei CH, Hu ZQ, Srivastava K, Ko J, Xi ST, et al. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol. 2005;116:517–524
  8. Engler RJ. Alternative and complementary medicine: a source of improved therapies for asthma? a challenge for redefining the specialty?. J Allergy Clin Immunol. 2000;106:627–629
  9. US Food and Drug Administration Center for Drug Evaluation and Research. Guidance for industry botanical drug products. Washington, DC: US Food and Drug Administration; 2000.
  10. Bensky D, Barolet R. Chinese herbal medicine: formulas & strategies. Seattle: Eastland Press; 1990;
  11. Bielory L, Lupoli K. Herbal interventions in asthma and allergy. J Asthma. 1999;36:1–65
  12. Li XM, Zhang TF, Sampson H, Zou ZM, Beyer K, Wen MC, et al. The potential use of Chinese herbal medicines in treating allergic asthma. Ann Allergy Asthma Immunol. 2004;93:S35–S44
  13. Li XM, Huang CK, Zhang TF, Teper AA, Srivastava K, Schofield BH, et al. The Chinese herbal medicine formula MSSM-002 suppresses allergic airway hyperreactivity and modulates TH1/TH2 responses in a murine model of allergic asthma. J Allergy Clin Immunol. 2000;106:660–668
  14. Ko J, Busse PJ, Shek L, Noone SA, Sampson HA, Li XM. Effect of Chinese herbal formulas on T-cell responses in patients with peanut allergy or asthma. [abstract] J Allergy Clin Immunol. 2005;115:S34
  15. Busse PJ, Wen MC, Huang CK, Srivastava K, Zhang TF, Schofield B, et al. Therapeutic effects of the Chinese herbal formula, MSSM-03d, on persistent airway hyperreactivity and airway remodeling. [abstract] J Allergy Clin Immunol. 2004;113:S220
  16. Srivastava K, Zou ZM, Sampson HA, Dansky H, Li XM. Direct modulation of airway reactivity by the Chinese anti-asthma herbal formula ASHMI. [abstract] J Allergy Clin Immunol. 2005;115:S7
  17. Bolleddula J, Goldfarb J, Wang R, Sampson H, Li XM. Synergistic modulation of eotaxin and IL-4 secretion by constituents of an anti-asthma herbal formula (ASHMI) in vitro. [abstract] J Allergy Clin Immunol. 2007;119:S172
  18. Hsu CH, Lu CM, Chang TT. Efficacy and safety of modified Mai-Men-Dong-Tang for treatment of allergic asthma. Pediatr Allergy Immunol. 2005;16:76–81
  19. Chan CK, Kuo ML, Shen JJ, See LC, Chang HH, Huang JL. Ding Chuan Tang, a Chinese herb decoction, could improve airway hyper-responsiveness in stabilized asthmatic children: a randomized, double-blind clinical trial. Pediatr Allergy Immunol. 2006;17:316–322
  20. Chang TT, Huang CC, Hsu CH. Clinical evaluation of the Chinese herbal medicine formula STA-1 in the treatment of allergic asthma. Phytother Res. 2006;20:342–347
  21. Chang TT, Huang CC, Hsu CH. Inhibition of mite-induced immunoglobulin E synthesis, airway inflammation, and hyperreactivity by herbal medicine STA-1. Immunopharmacol Immunotoxicol. 2006;28:683–695
  22. Hoang BX, Shaw DG, Levine S, Hoang C, Pham P. New approach in asthma treatment using excitatory modulator. Phytother Res. 2007;21:554–557
  23. Hope BE, Massey DG, Fournier-Massey G. Hawaiian materia medica for asthma. Hawaii Med J. 1993;52:160–166
  24. Massey DG, Chien YK, Fournier-Massey G. Mamane: scientific therapy for asthma?. Hawaii Med J. 1994;53:350–351363
  25. Wen MC, Huang CK, Srivastava KD, Zhang TF, Schofield B, Sampson HA, et al. Ku-Shen (Sophora flavescens Ait), a single Chinese herb, abrogates airway hyperreactivity in a murine model of asthma. [abstract] J Allergy Clin Immunol. 2004;113:218
  26. Kim JY, Kim DY, Lee YS, Lee BK, Lee KH, Ro JY. DA-9601, Artemisia asiatica herbal extract, ameliorates airway inflammation of allergic asthma in mice. Mol Cells. 2006;22:104–112
  27. Fang SP, Tanaka T, Tago F, Okamoto T, Kojima S. Immunomodulatory effects of gyokuheifusan on INF-gamma/IL-4 (Th1/Th2) balance in ovalbumin (OVA)-induced asthma model mice. Biol Pharm Bull. 2005;28:829–833
  28. Beyer K, Morrow E, Li XM, Bardina L, Bannon GA, Burks AW, et al. Effects of cooking methods on peanut allergenicity. J Allergy Clin Immunol. 2001;107:1077–1081
  29. Wang YM, Huan GX. Utilization of classical formulas. Beijing: Chinese Medicine and Pharmacology Publishing Co; 1998;
  30. Wen MC, Taper A, Srivastava KD, Huang CK, Schofield B, Li XM. Immunology of T cells by the Chinese herbal medicine Ling Zhi (Ganoderma lucidum). [abstract] J Allergy Clin Immunol. 2003;111:S320
  31. Li XM, Serebrisky D, Lee SY, Huang CK, Bardina L, Schofield BH, et al. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol. 2000;106:150–158
  32. Li XM, Zhang TF, Huang CK, Srivastava K, Teper AA, Zhang L, et al. Food allergy herbal formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol. 2001;108:639–646
  33. Li XM, Schofield BH, Huang CK, Kleiner GA, Sampson HA. A murine model of IgE mediated cow milk hypersensitivity. J Allergy Clin Immunol. 1999;103:206–214
  34. Srivastava KD, Kattan JD, Zou ZM, Li JH, Zhang L, Wallenstein S, et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol. 2005;115:171–178
  35. Srivastava KD, Zhang TF, Qu C, Sampson HA, Li XM. Silencing peanut allergy: a Chinese herbal formula, FAHF-2, completely blocks peanut-induced anaphylaxis for up to 6 months following therapy in a murine model of peanut allergy. [abstract] J Allergy Clin Immunol. 2006;117:S328
  36. Qu C, Srivastava KD, Ko J, Zhang TF, Sampson HA, Li XM. Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula (AFHF)-2 is associated with upregulation of IFN-gamma. Clin Exp Allergy. 2007;37:846–855
  37. Li XM. Beyond allergen avoidance: update on developing therapies for peanut allergy. Curr Opin Allergy Clin Immunol. 2005;5:287–292
  38. Kattan JD, Srivastava KD, Sampson HA, Li XM. Pharmacologic and immunologic effects of individual herbs of food allergy herbal formula 2 in a murine model of peanut allergy. [abstract] J Allergy Clin Immunol. 2006;117:S34
  39. State Pharmacopoeia Commission of the People's Republic of China . Pharmacopoeia of the People's Republic of China. English ed. Beijing: Chemical Industry Press; 2005;

 Supported by National Institutes of Health/Center for Complementary and Alternative Medicine Grant #1P01 AT002644725-01, National Institutes of Health/Center for Complementary and Alternative Medicine R01 AT001-14, National Institutes of Health Grant RR 00071, the Food Allergy Initiative, the Rothstein family, and the Cornfield Family Foundation. US Provisional Patent Application regarding FAHF-2 (reference number 60554775) and ASHMI (reference number 60554607) have been filed.Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(07)00862-7

doi: 10.1016/j.jaci.2007.04.030

The Journal of Allergy and Clinical Immunology
Volume 120, Issue 1 , Pages 25-31 , July 2007

Article Tools